百济神州：Sales exceeding expectations and achieving non-GAAP profitability

9 Aug 2024 CMB International Global Markets | Equity Research | Company Update BeiGene (BGNE US) Sales exceeding expectations and achieving nonGAAP profitability Product sales continued beating expectations. In 2Q24, BeiGene recorded total product sales of US$921mn (+23% QoQ, +66% YoY). The 1H24 total product sales reached US$1.67bn, representing 51.4% of our previous FY24 estimate, beating our expectations. Zanubrutinib (zanu) maintained strong sales momentum, increasing 30% QoQ or 107% YoY to US$637mn. Th ...